Pfizer Buys Biohaven for US$11.6 B

By Lucy Haggerty

Pharma Deals Review: Vol 2022 Issue 5 (Table of Contents)

Published: 13 May-2022

DOI: 10.3833/pdr.v2022.i5.2690     ISSN: 1756-7874

Section: Mergers & Acquisitions



In the biggest buyout of 2022 so far, Pfizer has agreed to acquire Biohaven Pharmaceutical for US$148...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details